0
Researchers have described a new approach that uses machine learning to hunt for disease targets and then predicts whether a drug is likely to receive FDA approval.
Researchers have described a new approach that uses machine learning to hunt for disease targets and then predicts whether a drug is likely to receive FDA approval.